Published in J Mater Sci Mater Med on November 22, 2006
Nanotopographical modification: a regulator of cellular function through focal adhesions. Nanomedicine (2010) 1.55
The relative importance of topography and RGD ligand density for endothelial cell adhesion. PLoS One (2011) 0.97
Nanocharacterization in dentistry. Int J Mol Sci (2010) 0.87
The Control of Mesenchymal Stromal Cell Osteogenic Differentiation through Modified Surfaces. Stem Cells Int (2013) 0.82
Selective modulation of cell response on engineered fractal silicon substrates. Sci Rep (2013) 0.79
Entropic elasticity of lambda-phage DNA. Science (1994) 15.40
Bone indentation recovery time correlates with bond reforming time. Nature (2001) 2.82
Topography and mechanical properties of single molecules of type I collagen using atomic force microscopy. Biophys J (2005) 1.59
In situ atomic force microscopy of partially demineralized human dentin collagen fibrils. J Struct Biol (2002) 1.45
Subfibrillar structure of type I collagen observed by atomic force microscopy. Biophys J (1993) 1.30
Corneal and scleral collagens--a microscopist's perspective. Micron (2001) 1.24
Force spectroscopy of collagen fibers to investigate their mechanical properties and structural organization. Biophys J (2004) 1.19
Evidence that collagen fibrils in tendons are inhomogeneously structured in a tubelike manner. Biophys J (2003) 1.19
Scanning electron microscopy of type I collagen at the dentin-enamel junction of human teeth. J Histochem Cytochem (1993) 1.07
Atomic force microscopy study of the collagen fibre structure. Biol Cell (1994) 1.07
An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif Tissue Int (1995) 1.05
Human cornea and sclera studied by atomic force microscopy. Cell Tissue Res (1997) 0.96
Effect of citric acid concentration on dentin demineralization, dehydration, and rehydration: atomic force microscopy study. J Biomed Mater Res (1998) 0.92
Moisture-dependent renaturation of collagen in phosphoric acid etched human dentin. J Biomed Mater Res (1998) 0.88
Observation of human corneal and scleral collagen fibrils by atomic force microscopy. Jpn J Ophthalmol (2002) 0.84
Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression. Br J Haematol (2001) 0.83
Measurement of Howship's resorption lacunae by a scanning probe microscope system. J Electron Microsc (Tokyo) (1993) 0.75
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93
Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74
Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49
Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43
The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34
Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28
Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone (1996) 1.23
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. J Bone Miner Res (1992) 1.19
Adapting atomic force microscopy for cell biology. Ultramicroscopy (2000) 1.19
A nonradioactive biochemical characterization of membrane proteins using enhanced chemiluminescence. Anal Biochem (1992) 1.15
Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol (1988) 1.13
Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner (1986) 1.13
Atomic force microscopy can be used to mechanically stimulate osteoblasts and evaluate cellular strain distributions. Ultramicroscopy (2001) 1.11
Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology (1996) 1.08
Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer (1991) 1.06
Human mast cells detected by monoclonal antibodies. J Clin Pathol (1984) 1.06
Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J Clin Invest (1994) 1.04
Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol (1991) 1.03
Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol (1991) 1.02
Increased expression of laminin/collagen receptor (VLA-1) on epithelium of inflamed human intestine. J Clin Pathol (1990) 1.02
New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Miner (1990) 1.01
Expression of the VLA family of integrins in human intestine. J Pathol (1990) 1.01
Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy. J Cell Sci (1993) 1.00
Integrins on rat osteoclasts: characterization of two monoclonal antibodies (F4 and F11) to rat beta 3. J Bone Miner Res (1992) 1.00
Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia. Br J Cancer (1991) 1.00
Characterization of integrin chains in normal and neoplastic human pancreas. J Pathol (1991) 1.00
Hypoxia induces giant osteoclast formation and extensive bone resorption in the cat. Calcif Tissue Int (2006) 0.99
Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Sci (1993) 0.99
Immunohistochemical detection of parathyroid hormone-related protein in human fetal epithelia. J Clin Endocrinol Metab (1991) 0.99
The identification and cloning of a murine major basic protein gene expressed in eosinophils. J Immunol (1995) 0.98
Characterization of human mast cells in long-term culture. Blood (1983) 0.97
Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo. J Immunol (2000) 0.94
A new specialized cell-matrix interaction in actively resorbing osteoclasts. J Cell Sci (2000) 0.94
Human fetal osteoclasts fail to express macrophage antigens. Br J Exp Pathol (1985) 0.94
Adhesive properties of isolated chick osteocytes in vitro. Bone (1996) 0.92
Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. Endocrinology (2001) 0.92
Human osteoclast-specific antigens are expressed by osteoclasts in a wide range of non-human species. Br J Exp Pathol (1986) 0.91
Genetic basis for Ly-6- defect: complementation between Ly-6- and Thy-1- mutant cell lines. Immunogenetics (1983) 0.89
On the origin of the osteoclast: the cell surface phenotype of rodent osteoclasts. Calcif Tissue Int (1985) 0.89
Haematological features of angioimmunoblastic lymphadenopathy with dysproteinaemia. J Clin Pathol (1979) 0.89
Leiomyosarcoma of the saphenous vein. J Pathol (1975) 0.88
Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Int J Cancer (1979) 0.88
Identification of human osteoclasts with monoclonal antibodies. N Engl J Med (1985) 0.86
Integrated confocal and scanning probe microscopy for biomedical research. ScientificWorldJournal (2006) 0.86
Calcitonin receptors of human osteoclastoma. Horm Metab Res (1987) 0.84
Focused ion beam milling and ultramicrotomy of mineralised ivory dentine for analytical transmission electron microscopy. Micron (2008) 0.84
Letter: HL-A and pernicious anemia. N Engl J Med (1976) 0.84
Expression of transferrin receptors during erythroid maturation. Exp Cell Res (1983) 0.83
Blood leukocytes bind platelet glycoprotein (IIb-IIIa)' but do not express the vitronectin receptor. Int Immunol (1990) 0.83
Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression. Br J Haematol (2001) 0.83
Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts. Bone (2000) 0.83
Cells in regenerating deer antler cartilage provide a microenvironment that supports osteoclast differentiation. J Exp Biol (2001) 0.83
Identification of two normal bcr gene products in the cytoplasm. Oncogene (1988) 0.82
Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis. J Bone Miner Res (2000) 0.82
Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions. Exp Cell Res (1995) 0.82
Mineralised tissues as nanomaterials: analysis by atomic force microscopy. IEE Proc Nanobiotechnol (2005) 0.81
Osteoclasts: putative, surrogate and authentic. J Pathol (1984) 0.81
Peanut agglutinin. V. Thymocyte subpopulations in the mouse studied with peanut agglutinin and Ly-6.2 antiserum. J Immunol (1980) 0.81
Cell membrane glycoproteins of human mast cells: a biochemical comparison with basophils. Exp Hematol (1986) 0.81
The effect of histamine H2 receptor antagonists on platelet aggregation in man. Scand J Haematol (1983) 0.81
Expression of red cell specific determinants during differentiation in the K562 erythroleukaemia cell line. Scand J Haematol (1981) 0.80
Estrogen receptors and human bone cells: immunocytochemical studies. J Bone Miner Res (1989) 0.80
Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome. Hematol Oncol (1990) 0.80
HLA antigen (A & B loci) frequency in Addisonian pernicious anaemia. Tissue Antigens (1976) 0.80
Integrin-dependent mobilization of intracellular calcium ions in osteoclasts. A possible role in the regulation of the secretion of protons and lysosomal enzymes. Ann N Y Acad Sci (1994) 0.79
An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur J Cancer (2000) 0.79
Recapitulation of the parathyroid hormone-related peptide-Indian hedgehog pathway in the regenerating deer antler. Dev Dyn (2004) 0.79
Reversible C3 hypocomplementaemia in megaloblastic anaemia due to vitamin B12 deficiency. Br J Haematol (1977) 0.78
Origin of human mast cells studied by dual immunofluorescence. Clin Exp Immunol (1987) 0.78
Adhesion receptors are differentially expressed on developing thymocytes and epithelium in human thymus. Exp Hematol (1992) 0.78
Histamine H2 receptors and intrinsic factor secretion. Scand J Gastroenterol (1980) 0.78
Multiple differentiation programs in K562 erythroleukemia cells and their regulation. Prog Clin Biol Res (1983) 0.78
Expression of the vitronectin receptor during embryonic development; an immunohistological study of the ontogeny of the osteoclast in the rabbit. Br J Exp Pathol (1989) 0.78
Granulopoiesis in the neutropenia of negroes. Scand J Haematol (1983) 0.78
Is intrinsic factor really affected by cimetidine? Br Med J (1979) 0.77
Familial mastocytosis: a clinical, immunophenotypic, light and electron microscopic study. Br J Dermatol (1991) 0.77
An assessment of the ability of human bone marrow cultures to generate osteoclasts. Int J Exp Pathol (1992) 0.77
Interleukin-4 and interleukin-13: bidirectional effects on human osteoclast formation. Bone (2001) 0.77
Expression of myeloid-specific antigens on two human erythroleukaemia cell lines, HEL and K562. Leuk Res (1984) 0.77
New technologies in scanning probe microscopy for studying molecular interactions in cells. Expert Rev Mol Med (2000) 0.77
Expression of platelet glycoprotein IIIa by human osteoclasts. Blood (1986) 0.77
Identifying early osteoclastic resorptive lesions in feline teeth: a model for understanding the origin of multiple idiopathic root resorption. J Periodontal Res (2008) 0.77
Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis. J Bone Miner Res (1999) 0.76
Unusual myeloid leukaemia in patient with Hodgkin's disease. J Clin Pathol (1987) 0.75
When is it an osteoclast? J Clin Pathol (1985) 0.75
Analysis of the surface characteristics and mineralization status of feline teeth using scanning electron microscopy. J Anat (2006) 0.75
Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL). Br J Cancer (1989) 0.75
High colony stimulating activity in a patient with disseminated carcinoma and neutrophil leucocytosis. J Clin Pathol (1984) 0.75
Cellular heterogeneity in giant cell tumour of bone (osteoclastoma): an immunohistological study of 16 cases. Histopathology (1988) 0.75
Nanoscale scraping and dissection of collagen fibrils. Nanotechnology (2008) 0.75
A suggested current literature and reference library for respiratory and chest physical therapists. Respir Care (1979) 0.75